BR9710031A - Tratamento de incontinência urinária utilizando (s)-Oxibutinina e (s)-Desetiloxibutinina - Google Patents

Tratamento de incontinência urinária utilizando (s)-Oxibutinina e (s)-Desetiloxibutinina

Info

Publication number
BR9710031A
BR9710031A BR9710031A BR9710031A BR9710031A BR 9710031 A BR9710031 A BR 9710031A BR 9710031 A BR9710031 A BR 9710031A BR 9710031 A BR9710031 A BR 9710031A BR 9710031 A BR9710031 A BR 9710031A
Authority
BR
Brazil
Prior art keywords
desethyloxybutynin
oxybutynin
treatment
urinary incontinence
incontinence
Prior art date
Application number
BR9710031A
Other languages
English (en)
Inventor
Gunnar Aberg
John R Mccullough
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of BR9710031A publication Critical patent/BR9710031A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BR9710031A 1996-06-28 1997-06-27 Tratamento de incontinência urinária utilizando (s)-Oxibutinina e (s)-Desetiloxibutinina BR9710031A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/671,976 US5736577A (en) 1995-01-31 1996-06-28 Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
PCT/US1997/011570 WO1998000126A1 (en) 1996-06-28 1997-06-27 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin

Publications (1)

Publication Number Publication Date
BR9710031A true BR9710031A (pt) 1999-08-10

Family

ID=24696647

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710031A BR9710031A (pt) 1996-06-28 1997-06-27 Tratamento de incontinência urinária utilizando (s)-Oxibutinina e (s)-Desetiloxibutinina

Country Status (14)

Country Link
US (1) US5736577A (pt)
EP (1) EP0914113A1 (pt)
JP (1) JP2000513724A (pt)
AU (1) AU732568B2 (pt)
BR (1) BR9710031A (pt)
CA (1) CA2257121C (pt)
CZ (1) CZ428398A3 (pt)
NO (1) NO985896D0 (pt)
NZ (1) NZ333282A (pt)
PL (1) PL190483B1 (pt)
RU (1) RU2195276C2 (pt)
SK (1) SK178698A3 (pt)
UA (1) UA61916C2 (pt)
WO (1) WO1998000126A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123961A (en) * 1996-09-25 2000-09-26 Bridge Pharma, Inc. Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin
US6130242A (en) * 1997-12-31 2000-10-10 Sepracor Inc. S-procyclidine for treating urinary incontinence
US20010038855A1 (en) * 1998-06-05 2001-11-08 Desjardin Michael A. Dosage form for administering prescribed dose
WO2000071108A2 (en) * 1999-05-20 2000-11-30 Sepracor Inc. Methods for treatment of asthma using s-oxybutynin
WO2000076490A2 (en) * 1999-06-10 2000-12-21 Sepracor Inc. Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin
US6248359B1 (en) 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US20030124177A1 (en) * 2000-04-26 2003-07-03 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
CN102327253A (zh) * 2000-04-26 2012-01-25 沃特森药物公司 最小化与奥昔布宁疗法有关的副作用
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
AU2001282064B2 (en) * 2000-08-03 2007-02-01 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US6545046B2 (en) 2000-08-30 2003-04-08 Theramax Inc. Method for enhanced delivery of oxybutynin and compositions thereof
DE10103262A1 (de) * 2001-01-25 2002-08-01 Axel Schmidt-Dossi Arzneimittel gegen Blasenfunktionsstörung
IL157771A0 (en) * 2001-03-27 2004-03-28 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
WO2002096855A2 (en) * 2001-04-03 2002-12-05 Aryx Therapeutics Anticholinergic compounds and methods of use
US20030027856A1 (en) * 2001-06-29 2003-02-06 Aberg A.K. Gunnar Tolterodine metabolites
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
BR0206300A (pt) * 2001-11-05 2008-04-08 Upjohn Co composição farmacêutica para tratar distúrbio urinário em um mamìfero e uso
US7921999B1 (en) * 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
EP1386604A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
NZ546106A (en) * 2003-10-10 2008-10-31 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
KR20150011379A (ko) * 2007-05-30 2015-01-30 마이크로도스 테라퍼스, 인코포레이티드 옥시부티닌 투여를 위한 방법 및 조성물
JP5782635B2 (ja) * 2011-01-12 2015-09-24 有限会社センチュリーテック 搬送装置
EP3909570A1 (de) * 2020-05-15 2021-11-17 Farco-Pharma GmbH Oxybutynin für die intravesikale anwendung
DE202020103897U1 (de) * 2020-05-15 2021-08-17 Farco-Pharma Gmbh Oxybutynin für die intravesikale Anwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL267508A (pt) * 1960-07-26
JPH0755904B2 (ja) * 1986-05-14 1995-06-14 小玉株式会社 膀胱疾患治療剤
MX9202350A (es) * 1991-05-20 1992-11-01 Alza Corp Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.
CA2167526A1 (en) * 1993-09-29 1995-04-06 Lina Tormen Taskovich Monoglyceride/lactate ester permeation enhancer
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin

Also Published As

Publication number Publication date
CA2257121C (en) 2006-10-24
UA61916C2 (en) 2003-12-15
SK178698A3 (en) 1999-09-10
NO985896L (no) 1998-12-16
WO1998000126A1 (en) 1998-01-08
RU2195276C2 (ru) 2002-12-27
AU732568B2 (en) 2001-04-26
CA2257121A1 (en) 1998-01-08
AU3513797A (en) 1998-01-21
NZ333282A (en) 2000-06-23
PL330752A1 (en) 1999-05-24
NO985896D0 (no) 1998-12-16
CZ428398A3 (cs) 1999-06-16
PL190483B1 (pl) 2005-12-30
JP2000513724A (ja) 2000-10-17
EP0914113A1 (en) 1999-05-12
US5736577A (en) 1998-04-07

Similar Documents

Publication Publication Date Title
BR9710031A (pt) Tratamento de incontinência urinária utilizando (s)-Oxibutinina e (s)-Desetiloxibutinina
EE9700267A (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
AU7608396A (en) Devices and methods for assessment and treatment of urinary and fecal incontinence
GB9425578D0 (en) redial treatment of urinary incontinence
DK0854691T3 (da) Kirurgisk instrument til behandling af urinkontinens hos kvinder
DE69725484D1 (de) Vorrichtung zur Behandlung von Harninkontinenz
DK0778749T3 (da) Kirurgisk instrument til behandling af urininkontinens hos kvinder
DE69618176D1 (de) Weiches behandeltes tissue
DE69724386D1 (de) Stimulationsvorrichtung zur Verhinderung der Harninkontinenz
IL138871A0 (en) Flushable diaper and method
DE69729841D1 (de) Prothese zur wiederherstellung der hernia und weichem gewebe
BR9609132A (pt) Composicão e método de tratamento de semente
ZA978427B (en) Method of treating urinary incontinence
FI956339A (fi) Hypotalaamisen kuukautisten puuttumisen hoitaminen
PT935692E (pt) Tratamento de tecido com celulase e oxidoredutase
ZA971607B (en) Methods of treatment of allergic diseases
HUP0104514A2 (en) The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence
AU1196601A (en) Methods of diagnosing and treating urinary incontinence
FR2759290B1 (fr) Minalcipran pour le traitement de l'incontinence urinaire
IL141264A0 (en) Treatment of fecal incontinence
AU6619398A (en) Treatment of urinary incontinence
CA76291S (en) Device for treatment of incontinence of urine
UA1517S (uk) Система самоутримувального дренажу для сечоходу
BR9302374A (pt) Metodo de tratamento de tecido e tecido obtido
GB2324962B (en) Treatment of allergic conditions

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1836 DE 14/03/2006.